Rossari Biotech Limited Stock Current Asset

ROSSARI Stock   826.15  18.40  2.18%   
Rossari Biotech Limited fundamentals help investors to digest information that contributes to Rossari Biotech's financial success or failures. It also enables traders to predict the movement of Rossari Stock. The fundamental analysis module provides a way to measure Rossari Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rossari Biotech stock.
As of now, Rossari Biotech's Non Current Assets Total are increasing as compared to previous years. The Rossari Biotech's current Other Current Assets is estimated to increase to about 5.2 B, while Total Current Assets are projected to decrease to under 4.4 B.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Rossari Biotech Limited Company Current Asset Analysis

Rossari Biotech's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.

Current Asset

 = 

Cash

+

Deposits

+

Liquid Assets

More About Current Asset | All Equity Analysis
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
Competition

Rossari Total Assets

Total Assets

7.94 Billion

As of now, Rossari Biotech's Total Assets are increasing as compared to previous years.
In accordance with the recently published financial statements, Rossari Biotech Limited has a Current Asset of 0.0. This is 100.0% lower than that of the Chemicals sector and 100.0% lower than that of the Materials industry. The current asset for all India stocks is 100.0% higher than that of the company.

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Rossari Fundamentals

About Rossari Biotech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Rossari Biotech Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rossari Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rossari Biotech Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Rossari Stock

Rossari Biotech financial ratios help investors to determine whether Rossari Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rossari with respect to the benefits of owning Rossari Biotech security.